Atarax and Cresemba drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atarax (hydroxyzine hydrochloride) and Cresemba (isavuconazonium sulfate). Common drug interactions include septic shock among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Atarax and Cresemba. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Atarax?

Atarax has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 23,553 Atarax users. Check the latest studies of Atarax.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

On Jul, 17, 2026

11 people who take Atarax and Cresemba together, and have interactions are studied.

What are the common drug interactions of Atarax and Cresemba, by gender? *:

female:

Septic shock (shock due to blood infection)
Stomatitis (inflammation of mucous membrane of mouth)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Gamma-glutamyltransferase increased
Mixed liver injury
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Cardiogenic shock (inadequate circulation of blood)
Gastrointestinal inflammation (inflammation of stomach and intestine)

male:

Cardiac failure
Hepatic failure (liver failure)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Soft tissue necrosis (death of soft tissue)

What are the common drug interactions of Atarax and Cresemba, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Soft tissue necrosis (death of soft tissue)
Cardiac failure
Hepatic failure (liver failure)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Gamma-glutamyltransferase increased
Mixed liver injury
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Cardiogenic shock (inadequate circulation of blood)
Gastrointestinal inflammation (inflammation of stomach and intestine)
Septic shock (shock due to blood infection)
Stomatitis (inflammation of mucous membrane of mouth)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 27.27%
B-Cell Lymphoma Recurrent (blood cancer affecting b cells-recurrent): 3 people, 27.27%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 2 people, 18.18%
Aspergillus Test Positive: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Atarax and Cresemba?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously